KSQ‐4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1‐Mediated Multidrug Resistant Cancers KSQ-4279, an USP1 inhibitor in clinical trial, widely reversed multidrug resistance in refractory cancers by competing for the drug-binding pockets of ABCB1/ABCG2/ABCC1 and blocking chemotherapeutic ...

#Article in #MedComm
KSQ-4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1-Mediated Multidrug Resistant Cancers doi.org/10.1002/mco2...

#MultidrugResistance #MDR #USP1 #ABC #KSQ4279 #CombinationChemotherapy